1220626-82-3

1220626-82-3 structure

Name: JNJ-49095397
Chemical Name: Jnj-49095397
CAS Number: 1220626-82-3
Molecular Formula: C₃₄H₃₆N₆O₄
Molecular Weight: 592.687
Catalog: Signaling Pathways MAPK/ERK Pathway p38 MAPK
Create Date: 2020-01-12 11:08:50
Modify Date: 2024-01-08 21:00:18
JNJ-49095397 (RV-568) is a specific narrow-spectrum kinase inhibitor that inhibits a selected set of kinases involved in COPD inflammation with IC50 of 5, 40 and 52 nM for p38α, p38γ and HCK, respectively; shows potent anti-inflammatory effects in monocytes and macrophages, demonstrates synergistic interaction in poly I:C-stimulated BEAS-2B cells and in the cigarette smoke model combined with corticosteroid. COPD Phase 2 Clinical

Name	Jnj-49095397
Synonyms	Jnj-49095397 Acetamide, N-[4-[[[4-[[[[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]amino]carbonyl]amino]-1-naphthalenyl]oxy]methyl]-2-pyridinyl]-2-methoxy- 2-Methoxy-N-[4-({[4-({[1-(4-methylphenyl)-3-(2-methyl-2-propanyl)-1H-pyrazol-5-yl]carbamoyl}amino)-1-naphthyl]oxy}methyl)-2-pyridinyl]acetamide

Description	JNJ-49095397 (RV-568) is a specific narrow-spectrum kinase inhibitor that inhibits a selected set of kinases involved in COPD inflammation with IC50 of 5, 40 and 52 nM for p38α, p38γ and HCK, respectively; shows potent anti-inflammatory effects in monocytes and macrophages, demonstrates synergistic interaction in poly I:C-stimulated BEAS-2B cells and in the cigarette smoke model combined with corticosteroid. COPD Phase 2 Clinical
References	References 1. Onions ST, et al. J Med Chem. 2016 Mar 10;59(5):1727-46. 2. Charron CE, et al. Eur Respir J. 2017 Oct 26;50(4). pii: 1700188. View Related Products by Target p38 MAPK COPD